Postoperative analgesia in plastic surgery


如何引用文章

全文:

详细

The review is devoted to the questions of prophylaxis and treatment of postoperative pain in plastic surgery. The pain in plastic surgery remains a serious problem in particular after major reconstructive-reparative operations. It impedes patient timely discharge from hospital in same-day surgery. Postoperative pain in plastic surgery may become chronic in 10-40% cases especially after operations on mammary glands. The basis of postoperative analgesia in plastic surgery is combined using of nonopioid analgesics (NSAIDs, paracetamol, gabapentin) and different variants of regional analgesia. Opioid analgesics are considered as reserve drugs for cases when nonopioid analgesia isn't effective.

作者简介

Alexei Ovechkin

I.M. Sechenov First Moscow State Medical University

Email: ovechkin_alexei@mail.ru
MD, PhD, DSc, professor, Head of the Department of anesthesiology and resuscitation Moscow, 119991, Russian Federation

A. Zvizhuleva

S.P. Botkin City Clinical Hospital of Department of Healthcare of Moscow

Moscow, 125284, Russian Federation

参考

  1. Fortier J., Chung F., Su J. Unanticipated admission after ambulatory surgery - a prospective study. Can. J. Anaesth. 1998; 45: 612-619.
  2. Pavlin D., Chen C., Penaloza D et al. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth. Analg. 2002; 95: 627-634.
  3. Pavlin D., Chen C., Penaloza D et al. A survey of pain and other symptoms that affect the recovery process after discharge from an ambulatory surgery unit. J. Clin. Anesth. 2004; 16: 200-206.
  4. Brandi L., Frediani M., Oleggini M. Insulin resistance after surgery: normalization by insulin treatment. Clinical Science. 1990; 79: 443-450.
  5. Page G., Blakely W., Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001; 90: 191-199.
  6. Endara M., Masden D., Goldstein J., Gondek S., Steinberg J., Attinger C. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. Plast. Reconstr. Surg. 2013; 132: 996-1004.
  7. Mioton L., Buck D., Rambachan A. Predictors of readmission after outpatient plastic surgery. Plast. Reconstr. Surg. 2014; 133: 173-180.
  8. Любошевский П.А., Овечкин А.М. Возможности оценки и коррекции хирургического стресс-ответа при операциях высокой травматичности. Регионарная анестезия и лечение острой боли. 2014; 4: 5-21.
  9. Macrae W. Chronic post-surgical pain: 10 years on. Br.J.Anaesth., 2008; 101: 77-86.
  10. von Sperling M., Hoimyr H., Finnerup K., Jensen T., Finnerup N. Persistent pain and sensory changes following cosmetic breast augmentation. Eur. J. Pain. 2011; 15: 328-332.
  11. Romundstad L., Breivik H., Roald H., Skolleborg K., Romundstad P., Stubhaug A. Chronic pain and sensory changes after augmentation mammoplasty: long term effects of preincisional administration of methylprednisolone. Pain. 2006; 124: 92-99.
  12. Wallace M., Wallace A.M, Lee J., Dobke M. Pain after breast surgery: a survey of 282 women. Pain. 1996; 66: 195-205.
  13. Nelson J., Fischer J., Pasick C. Chronic pain following abdominal free flap breast reconstruction: a prospective pilot analysis. Ann. Plast. Surg. 2013; 71: 278-282.
  14. Macdonald L., Bruce J., Scott N. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br. .J. Cancer. 2005; 92: 225-230.
  15. Beer G., Goldscheider E., Weber A et al. Prevention of acute hematoma after face-lifts. Aesthetic Plast. Surg. 2010; 34: 502-507.
  16. Frasco P., Sprung J., Trentman T. The impact of the joint commission for accreditation of healthcare organizations pain initiative on perioperative opiate consumption and recovery room length of stay. Anesth. Analg. 2005; 100: 162-168.
  17. Oderda G., Gan T., Johnson B. Effect of opioidrelated adverse events on outcomes in selected surgical patients. J. Pain Palliat. Care Pharmacother. 2013; 27: 62-70.
  18. Apfelbaum J., Chen C., Mehta S. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth. Analg. 2003; 97: 534-540.
  19. Abboushi N., Yezhelyev M., Symbas J. Facelift complications and the risk of venous thromboembolism: a single center’s experience. Aesthet Surg. J. 2012; 32: 413-420.
  20. Santos D., Tan M., Farias C. Venous thromboembolism after facelift surgery under local anesthesia: results of a multicenter survey. Aesthetic Plast. Surg. 2014; 38: 12-24.
  21. Lee A., Cooper M., Craig J. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst. Rev. 2007;2:CD002765.
  22. Lewis S., Nicholson A., Cardwell M. Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database Syst. Rev. 2013;7:CD003591.
  23. Gobble R., Hoang H., Kachniarz B. Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast. Reconstr. Surg. 2014; 133: 741-755.
  24. Wilson А., Mirzabeigi М., Serletti J. Putting It All Together: Managing pain in autologous and implant-based breast reconstruction. Plast. Reconstr. Surg. 2014; 134: 120-125.
  25. Parsa A., Soon C., Parsa F. The use of celecoxib for reduction of pain after subpectoral breast augmentation. Aesthetic Plast. Surg. 2005; 29: 441-444.
  26. Sun T., Sacan O., White P. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesth. Analg. 2008; 106: 950-958.
  27. Кузьмин В.В. Обезболивание нефопама гидрохлоридом в пластической хирургии. Регионарная анестезия и лечение острой боли, 2013; 2: 17-22.
  28. Waldron N., Jones C., Gan T. Impact of perioperative dexamethasone on postoperative analgesia and sideeffects: systematic review and meta-analysis. Br. J. Anaesth. 2013; 110: 191-200.
  29. Ying Hui Low, Tong J. Gan. NMDA Receptor Antagonists, Gabapentinoids, α-2 Agonists, and Dexamethasone and Other Non-Opioid Adjuvants: Do They Have a Role in Plastic Surgery? Plast. Reconstr. Surg. 2014; 134: 69-82.
  30. Baratta J., Schwenk E., Viscusi E. Clinical Consequences of Inadequate Pain - Relief: Barriers to Optimal Pain Management. Plast. Reconstr. Surg. 2014; 134: 15-21.
  31. Fassoulaki A., Triga A., Melemeni A. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth. Analg. 2005; 101: 1427-1432.
  32. Rubin J., Xie Z., Davidson C. Rapid absorption of tumescent lidocaine above the clavicles: a prospective clinical study. Plast. Reconstr. Surg. 2005; 115: 1744-1751.
  33. McKee D., Lalonde D., Thoma A. Optimal time delay between epinephrine injection and incision to minimize bleeding. Plast. Reconstr. Surg. 2013; 131: 811-814.
  34. Vigneault L., Turgeon A., Cote D. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can. J. Anaesth. 2011; 58:22-37.
  35. Swanson E. Prospective study of lidocaine, bupivacaine, and epinephrine levels and blood loss in patients undergoing liposuction and abdominoplasty. Plast. Reconstr. Surg. 2012; 130: 702-722.
  36. Zukowski M., Ash K., Klink B. Breast reduction under intravenous sedation: a review of 50 cases. Plast. Reconstr. Surg. 1996; 97: 952-956.
  37. Hardwicke J., Jordan R., Skillman J. Infiltration of epinephrine in reduction mammaplasty: a systematic review of the literature. Plast. Reconstr. Surg. 2012; 130: 773-778.
  38. Kaplan J., Rotemberg S., Yetman R. Breast reduction: does the tumescent technique affect reimbursement? Plast. Reconstr Surg. 2008; 122: 693-700.
  39. Gart M., Ko J., Heyer K. Breast implant procedures under conscious sedation: a 6-year experience in 461 consecutive patients. Plast. Reconstr. Surg. 2013; 131: 1169-1178.
  40. Chun Y., Verma K., Rosen H. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am. J. Surg. 2011; 201: 160-165.
  41. Pitman G. Discussion-tumescent technique for local anesthesia improves safety in large volume liposuction. Plast. Reconstr. Surg. 1993; 92: 1099-1100.
  42. Gutowski K. Tumescent analgesia in plastic surgery. Plast. Reconstr. Surg. 2014; 134: 50-57.
  43. Paik A., Daniali L., Lee E. Local anesthetic use in tumescent liposuction: an American Society of Plastic Surgeons (ASPS) survey. Plast. Reconstr. Surg. 2013; 132: 74.
  44. Failey C., Vemula R., Borah G. Intraoperative use of bupivacaine for tumescent liposuction: the Robert Wood Johnson experience. Plast. Reconstr. Surg. 2009; 124: 1304-1311.
  45. Klein J. Tumescent technique for local anesthesia improves safety in large volume liposuction. Plast. Reconstr. Surg. 1993; 92: 1086-1098.
  46. Ostad A., Kageyama N., Moy R. Tumescent anesthesia with a lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol. Surg. 1996; 22: 921-927.
  47. Pоpping D., Elia N., Van Aken H. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann. Surg. 2014; 259:1056-1067.
  48. Correll D., Viscusi E., Grunwald Z. Epidural analgesia compared with intravenous morphine patient-controlled analgesia: postoperative outcome measures after mastectomy with immediate TRAM flap breast reconstruction. Reg. Anesth. Pain Med. 2001; 26: 444-449.
  49. Cayci C., Cinar C., Yucel O. The effect of epidural anesthesia on muscle flap tolerance to venous ischemia. Plast. Reconstr. Surg. 2010; 125: 89-98.
  50. Fischer J., Nelson J., Wes A. The use of epidurals in abdominal wall reconstruction: an analysis of outcomes and cost. Plast. Reconstr. Surg. 2014; 133: 687-699.
  51. Joshi G., Kehlet H. Procedure-specific pain management: the road to improve postsurgical pain management? Anesthesiology. 2013; 118: 780-782.
  52. Joshi G., Schug S., Kehlet H. Procedure specific pain management and outcome strategies. Best Pract. Res. Clin. Anaesthesiol. 2014; 28: 191-201.
  53. Kehlet H., Jensen T., Woolf C. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367: 1618-1625.
  54. Richards B., Schleicher W., Zins J. Putting it all together: recommendations for improving pain management in plastic surgical procedures-surgical facial rejuvenation. Plast. Reconstr. Surg. 2014; 134: 108-112.
  55. Ramirez O. Anchor subperiosteal forehead lift: from open to endoscopic. Plast. Reconstr. Surg. 2001; 107: 868-871.
  56. Torgerson C., Yoskovitch A., Cole A. Postoperative pain management with ketorolac in facial plastic surgery patients. J. Otolaryngol. Head Neck Surg. 2008; 37: 888-893.
  57. Danilla S., Fontbona M., de Valdus V. Analgesic efficacy of lidocaine for suction-assisted lipectomy with tumescent technique under general anesthesia: a randomized, doublemasked, controlled trial. Plast. Reconstr. Surg. 2013; 132: 327-332.
  58. Wang G., Cao W. Tumescent liposuction: partitioning of lidocaine at a lower dose (252 mg/l). Dermatology. 2011; 222: 274-277.
  59. Grazer F., de Jong R. Fatal outcomes from liposuction: census survey of cosmetic surgeons. Plast. Reconstr. Surg. 2000; 105: 436-446.
  60. Burk R., Guzman-Stein G., Vasconez L. Lidocaine and epinephrine levels in tumescent technique liposuction. Plast. Reconstr. Surg. 1996; 97: 1379-1384.
  61. Rao R., Ely S., Hoffman R. Deaths related to liposuction. N Engl J Med. 1999; 340: 1471-1475.
  62. Kaunisto M., Jokela R., Tallgren M. Pain in 1,000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain. Anesthesiology. 2013; 119: 1410-1421.
  63. Theunissen M., Peters M., Bruce J. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin. J. Pain. 2012; 28: 819-841.
  64. Misra A., Chester D., Park A. A comparison of postoperative pain between DIEP and extended latissimus dorsi flaps in breast reconstruction. Plast. Reconstr. Surg. 2006; 117: 1108-1112.
  65. Bar-Meir E., Yueh J., Hess P. Postoperative pain management in DIEP flap breast reconstruction: identification of patients with poor pain control. Eplasty. 2010; 10: 483-491.
  66. Sharma S., Chang D., Koutz C. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast. Reconstr. Surg. 2001; 107: 352-355.
  67. Giordano S., Verajankorva E., Koskivuo I. Effectiveness of local anaesthetic pain catheters for abdominal donor site analgesia in patients undergoing free lower abdominal flap breast reconstruction: a meta-analysis of comparative studies. J. Plast Surg. Hand Surg. 2013; 47: 428-433.
  68. Strazisar B., Besic N., Ahcan U. Does a continuous local anaesthetic pain treatment after immediate tissue expander reconstruction in breast carcinoma patients more efficiently reduce acute postoperative pain-a prospective randomized study. World J. Surg. Oncol. 2014; 12: 16.
  69. Utvoll J., Beausang-Linder M., Mesic H., Raeder J. Brief report: improved pain relief using intermittent bupivacaine injections at the donor site after breast reconstruction with deep inferior epigastric perforator flap. Anesth. Analg. 2010; 110: 1191-1194.
  70. Cooter R., Rudkin G., Gardiner S. Day case breast augmentation under paravertebral blockade: a prospective study of 100 consecutive patients. Aesthetic Plast. Surg. 2007; 31: 666-673.
  71. Klein S., Bergh A., Steele S. Thoracic paravertebral block for breast surgery. Anesth. Analg. 2000; 90: 1402-1405.
  72. Tahiri Y., Tran de QH., Bouteaud J. General anaesthesia versus thoracic paravertebral block for breast surgery: a meta

版权所有 © Eco-Vector, 2016


 


##common.cookie##